Showing results (81-90 of 168) with videos related to

Sort By:
Pageof 17
Hematology Reports|June 25, 2026
Quality of Life in CAR-T Cell TherapyCaterina Alati, Martina Pitea, Gaetana Porto, et al.
Journal of Hematology & Oncology|March 18, 2016
The favorable role of homozygosity for killer immunoglobulin-like receptor (KIR) A haplotype in patients with advanced-stage classic Hodgkin lymphomaGiorgio La Nasa, Marianna Greco, Roberto Littera, et al.
Bone Marrow Transplantation|January 13, 2022
The association of graft-versus-leukemia effect and graft-versus host disease in haploidentical transplantation with post-transplant cyclophosphamide for AMLAvichai Shimoni, Myriam Labopin, Emanuele Angelucci, et al.
European Journal of Haematology|August 22, 2023
Case Report: CAR-T cells and subsequent maintenance with ponatinib in an adult Philadelphia acute lymphoblastic leukemia patient with hematological and extramedullary relapse after allogeneic stem cell transplantationFilippo Antonio Canale, Martina Pitea, Caterina Alati, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 19, 2014
Tolerability and efficacy of busulfan and fludarabine as allogeneic pretransplant conditioning therapy in acute myeloid leukemia: comparison with busulfan and cyclophosphamide regimenRoberta Fedele, Giuseppe Messina, Tiziana Martinello, et al.
Drug Design, Development and Therapy|July 15, 2021
Spotlight on Melphalan Flufenamide: An Up-and-Coming Therapy for the Treatment of MyelomaFortunato Morabito, Giovanni Tripepi, Enrica Antonia Martino, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 28, 2011
Plerixafor added to chemotherapy plus G-CSF is safe and allows adequate PBSC collection in predicted poor mobilizer patients with multiple myeloma or lymphomaImmacolata Attolico, Vincenzo Pavone, Angelo Ostuni, et al.
International Journal of Molecular Sciences|November 11, 2022
Chimeric Antigen Receptor T-Cell Therapy: What We Expect SoonMassimo Martino, Virginia Naso, Barbara Loteta, et al.
Cancers|February 27, 2026
Menin Inhibition in Acute Myeloid MLL Rearranged Leukemias: A New Target for Precision CareCaterina Alati, Matteo Molica, Martina Pitea, et al.
Bone Marrow Transplantation|March 6, 2021
Prognostic factors for neutrophil engraftment after haploidentical cell transplantation with PT-Cy in patients with acute myeloid leukemia in complete remission, on behalf of the ALWP-EBMTAnnalisa Ruggeri, Myriam Labopin, Emanuele Angelucci, et al.
Pageof 17